According to Jonsson, the company's clinical trials showed that the 5 mg dose of Zepbound helped users drop an average 15% of their starting weight within 72 weeks of therapy
However, some individuals prefer pills for ease of use
In 2022, a novel GLP-1 analog, semaglutide was introduced as an anti-obesity drug
You need 30-50g daily healthy fats to prevent gallbladder problems
For mothers with obesity-related health conditions requiring intervention, discussion with maternal-fetal medicine specialists and pediatricians can help weigh individual risk-benefit scenarios
Results A total of 222, 201 and 123 participants were recruited into groups 1, 2 and 3, respectively